awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37100647-4A592201-D0DE-4FBA-93A3-31E692911986
Q37100647-4A592201-D0DE-4FBA-93A3-31E692911986
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37100647-4A592201-D0DE-4FBA-93A3-31E692911986
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
P2860
Q37100647-4A592201-D0DE-4FBA-93A3-31E692911986
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37100647-4A592201-D0DE-4FBA-93A3-31E692911986
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3cf95408bcf0089f031b72291f55b32a9107943e
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.